INTERVAL LICENSING LLC v. AOL, INC.
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Federal Curcuit Summary
Before Taranto, Plager, and Chen. Appeal from the U.S. District Court for the Western District of Washington.
Summary: A patent claim is directed to an abstract idea where it broadly recites a result without defining how the result is achieved other than through implementation of generic computer functions.
In an earlier Federal Circuit decision, the Court vacated a judgment of noninfringement on 4 asserted patent claims. On remand, the district court held that those 4 claims were directed to patent ineligible subject matter under § 101. On a second appeal, the Federal Circuit affirmed. The claims were directed to an abstract idea: presenting two sets of information, in a non-overlapping way, on a display screen. The claims were result-centric. The patent did not explain how the claimed functionality was to be accomplished. The claimed instructions were recited at a high level of generality and did not impose meaningful limitations that would improve a computer as a tool.
Judge Plager concurred in the decision “given the current state of the law.” But he wrote separately to dissent from the court’s continued application of what he called an “incoherent body of doctrine” that “renders it near impossible to know with any certainty whether the invention is or is not patent eligible.”
This case is: INTERVAL LICENSING LLC v. AOL, INC.
Edited by: Paul Stewart
Written by: Peter Hecker and Mark Kachner
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…